{"id":"https://openalex.org/W2589201448","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4670","title":"The effect of inhibition of the insulin-like growth factor receptor with nordihydroguaiaretic acid on PSA progression: Results of a phase II study.","display_name":"The effect of inhibition of the insulin-like growth factor receptor with nordihydroguaiaretic acid on PSA progression: Results of a phase II study.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2589201448","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4670","mag":"2589201448"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.4670","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4670","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.4670","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079570071","display_name":"Terence W. Friedlander","orcid":"https://orcid.org/0000-0002-3630-4941","observed_orcids":["https://orcid.org/0000-0002-3630-4941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. W. Friedlander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039728792","display_name":"VIVIAN K. WEINBERG","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. K. Weinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022999202","display_name":"Carl Formaker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Formaker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006015931","display_name":"J. Mi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Mi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024203592","display_name":"Amy Lin","orcid":"https://orcid.org/0000-0001-7757-6719","observed_orcids":["https://orcid.org/0000-0001-7757-6719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. M. Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066372195","display_name":"Andrea Lynne Harzstark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. L. Harzstark","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Fong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. J. Small","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012804612","display_name":"Charles J. Ryan","orcid":"https://orcid.org/0000-0002-2081-3557","observed_orcids":["https://orcid.org/0000-0002-2081-3557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. J. Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"4670","last_page":"4670"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8682000041007996,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8682000041007996,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.12269999831914902,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nordihydroguaiaretic-acid","display_name":"nordihydroguaiaretic acid","score":0.9909999966621399},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.8769999742507935},{"id":"https://openalex.org/keywords/igf1r-inhibition","display_name":"IGF1R inhibition","score":0.9300000071525574},{"id":"https://openalex.org/keywords/hormone-sensitive-prostate-cancer","display_name":"hormone-sensitive prostate cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/prostate-specific-antigen-progression","display_name":"prostate-specific antigen progression","score":0.7910000085830688},{"id":"https://openalex.org/keywords/psa-doubling-time","display_name":"PSA doubling time","score":0.9610000252723694},{"id":"https://openalex.org/keywords/non-metastatic-prostate-cancer","display_name":"non-metastatic prostate cancer","score":0.8489999771118164},{"id":"https://openalex.org/keywords/oral-small-molecule-inhibitor","display_name":"oral small-molecule inhibitor","score":0.5509999990463257},{"id":"https://openalex.org/keywords/testosterone-levels","display_name":"testosterone levels","score":0.4749999940395355},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.42800000309944153},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4230000078678131},{"id":"https://openalex.org/keywords/igf-signaling-pathway","display_name":"IGF signaling pathway","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8366968631744385},{"id":"https://openalex.org/C2776889390","wikidata":"https://www.wikidata.org/wiki/Q7050774","display_name":"Nordihydroguaiaretic acid","level":4,"score":0.5904282331466675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5295133590698242},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.5085169076919556},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44467779994010925},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43774721026420593},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.42688149213790894},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.37997764348983765},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3563530445098877},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33029627799987793},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11552861332893372},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0934537947177887},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C2778078955","wikidata":"https://www.wikidata.org/wiki/Q407699","display_name":"Arachidonic acid","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.4670","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4670","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.4670","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2059030688","https://openalex.org/W1836586572","https://openalex.org/W2306089631","https://openalex.org/W4248466837","https://openalex.org/W2159753688","https://openalex.org/W1894792990","https://openalex.org/W2037868046","https://openalex.org/W2067337319","https://openalex.org/W2034696434","https://openalex.org/W3028896781"],"abstract_inverted_index":{"4670":[0],"Background:":[1],"Insulin-like":[2],"growth":[3],"factor":[4],"(IGF)":[5],"mediated":[6],"signaling":[7,30],"is":[8,19],"a":[9,44,68,75,109,119,153,331],"newly":[10],"recognized":[11],"clinical":[12],"target":[13],"in":[14,54,102,128,237,248,264,288,337],"prostate":[15,58,70],"cancer,":[16],"and":[17,31,74,85,137,188,222,278,291,300,307],"it":[18],"hypothesized":[20],"that":[21],"blockade":[22],"of":[23,40,48,111,124,135,139,141,152,244],"the":[24,38,49,160],"IGF-receptor":[25],"(IGF-1R)":[26],"will":[27],"impair":[28],"downstream":[29],"slow":[32],"tumor":[33],"growth.":[34],"In":[35],"this":[36],"study":[37,226,272,328],"efficacy":[39,158],"nordihydroguaiaretic":[41],"acid":[42],"(NDGA),":[43],"small":[45],"molecule":[46],"inhibitor":[47],"IGF-1R,":[50],"was":[51,81,95,116,168,181,192,203,269],"prospectively":[52],"evaluated":[53],"patients":[55,63,113,163,212,217,233,250,280],"with":[56,67,108,131],"hormone-sensitive":[57],"cancer":[59],"(HSPC).":[60],"Methods:":[61],"Eligible":[62],"had":[64],"non-metastatic":[65],"HSPC":[66],"rising":[69],"specific":[71],"antigen":[72],"(PSA)":[73],"normal":[76],"testosterone":[77,191],"level.":[78],"NDGA":[79,315],"2000mg":[80],"given":[82],"orally":[83],"daily":[84],"treatment":[86,202],"continued":[87],"until":[88],"PSA":[89,123,167,177,238,261,325],"progression":[90,262],"or":[91],"toxicity.":[92],"Sample":[93],"size":[94],"calculated":[96],"to":[97,106,148,173,186,197,208,219,229,242,253,258,298,333,346],"look":[98],"for":[99,150,157,210,273],"an":[100,132],"improvement":[101],"response":[103],"from":[104,121,227,240],"15%":[105],"35%":[107],"total":[110],"28":[112],"planned.":[114],"Response":[115],"defined":[117],"as":[118],"decline":[120],"baseline":[122,166,176,190],"\u226550%.":[125],"Accrual":[126,144],"occurred":[127,263,287],"2":[129,276,279],"stages":[130],"overall":[133],"power":[134],"81%":[136],"level":[138],"significance":[140],"5%.":[142],"Results:":[143],"has":[145],"been":[146,224],"halted":[147],"allow":[149],"follow-up":[151],"pre-planned":[154],"interim":[155],"analysis":[156],"among":[159],"first":[161],"12":[162],"enrolled.":[164],"Median":[165,199],"5.1":[169],"ng/mL":[170],"(range":[171,184,195,206,256],"1.5":[172],"9.1),":[174],"median":[175,189,318],"doubling":[178],"time":[179,200],"(PSADT)":[180],"8.2":[182],"months":[183,205],"6.7":[185],"15.4),":[187],"353":[193],"ng/dL":[194],"202":[196],"521).":[198],"on":[201,225],"6":[204,249],"1":[207,267,289],"11)":[209],"8":[211],"now":[213],"off":[214,271],"study;":[215],"4":[216],"continue":[218],"receive":[220],"therapy":[221,316],"have":[223],"5":[228,265],"17":[230],"months.":[231],"Eight":[232],"experienced":[234],"non-sustained":[235],"declines":[236],"ranging":[239],"2%":[241],"16%":[243],"baseline.":[245],"PSADT":[246,255,319,338],"lengthened":[247],"when":[251],"compared":[252],"pretreatment":[254],"2.5":[257],"16.2":[259],"months).":[260],"patients,":[266],"patient":[268,290],"taken":[270],"recurrent":[274],"grade":[275,284],"weakness,":[277],"withdrew":[281],"consent.":[282],"All":[283],"3":[285],"events":[286],"included":[292],"nausea/vomiting,":[293],"cognitive":[294],"disturbance,":[295],"syncope":[296],"due":[297],"dehydration,":[299],"elevated":[301],"liver":[302],"function":[303],"tests.":[304],"Testosterone,":[305],"dihydrotestosterone,":[306],"androstenedione":[308],"levels":[309],"were":[310],"not":[311,322],"significantly":[312],"changed.":[313],"Conclusions:":[314],"lengthens":[317],"but":[320],"does":[321],"induce":[323],"significant":[324,343],"declines.":[326],"Further":[327],"may":[329],"require":[330],"placebo-control":[332],"determine":[334],"if":[335],"changes":[336],"are":[339],"drug":[340],"related.":[341],"No":[342],"financial":[344],"relationships":[345],"disclose.":[347]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-03-03T00:00:00"}